Bixalomer
- Generic Name
- Bixalomer
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 851373-13-2
- Unique Ingredient Identifier
- 3160WY51LV
- Background
Bixalomer is under investigation in clinical trial NCT01115985 (A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers).
- Associated Conditions
- -
- Associated Therapies
- -
Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 144
- Registration Number
- NCT02805348
- Locations
- 🇯🇵
Site JP00004, Gifu, Japan
🇯🇵Site JP00001, Ibaraki, Japan
🇯🇵Site JP00003, Kanagawa, Japan
Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 123
- Registration Number
- NCT01903213
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath